Cite Filings / CTMX / 0001628280-25-050396

Feed Companies Filings Check

Sign in

144

Sale of Securities

CytomX Therapeutics, Inc. Filed 2025-11-06 Acc 0001628280-25-050396

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-11-10 4 CEO sold 101,793 shares at $4.54 ($461,906)
2025-11-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-06 144 Sale of Securities
2025-11-06 8-K Results of operations
2025-11-06 10-Q Quarterly Report
2025-11-05 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…